Subscribe: NewswireToday - Free Press Release - Free Newswire Distribution - Pharma/BioTech/Nutrition
http://www.newswiretoday.com/xml/17/
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
fda  francisco united  newswire  newswiretoday newswire  newswiretoday  san francisco  san  states  united states  united 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: NewswireToday - Free Press Release - Free Newswire Distribution - Pharma/BioTech/Nutrition

NewswireToday - Free Press Release - Free Newswire Distribution - Pharma/BioTech/Nutrition



Recent Pharma/BioTech/Nutrition NewswireToday - PRZOOM Headline News - Visit PressReleasesNewswireDistribution.com



Published: Sun, 24 Sep 2017 20:52:54 -0400

 



U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome

2017/09/18

NewswireToday (newswire) - 2017/09/18 Paris, Ile-de-France France - Ipsen announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental indication for Somatuline® Depot (lanreotide) Injection 120 mg for the treatment of carcinoid syndrome - IPSEN.com



Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration

2017/09/08

NewswireToday (newswire) - 2017/09/08 South San Francisco, CA United States - Genentech announced that the primary endpoint has not been met in Spectri, the first of two Phase III studies evaluating the safety and efficacy of lampalizumab - Gene.com



mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution

2017/09/06

NewswireToday (newswire) - 2017/09/06 Boston, MA United States - mProve Health integrates ClinCard with its patient engagement app to boost retention, compliance and improve patients’ clinical trial experience - mProve.com / Greenphire.com



FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome

2017/08/30

NewswireToday (newswire) - 2017/08/30 South San Francisco, CA United States - Genentech announced that FDA has approved Actemra® (tocilizumab) intravenous injection for the treatment of chimeric antigen receptor (CAR) T cell-induced severe or life-threatening cytokine release syndrome (CRS) in patients two years of age and older



Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management

2017/08/29

NewswireToday (newswire) - 2017/08/29 San Diego, CA United States - BD, Direct Relief and the National Association of Community Health Centers (NACHC) honored five of the nation's 1,400 community health centers with the Innovations in Care Award at the 2017 Community Health Institute and EXPO in San Diego - DirectRelief.o



Greenphire Named to Inc. 5000 for Fifth Consecutive Year

2017/08/29

NewswireToday (newswire) - 2017/08/29 King of Prussia, PA United States - Global leader in clinical trial payment automation experiences continued growth as a result of increasing industry demand for clinical trial payment lifecycle efficiencies - Inc.com / Greenphire.com



FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma

2017/08/28

NewswireToday (newswire) - 2017/08/28 South San Francisco, CA United States - Genentech announced that FDA has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority Review for Gazyva® - Gazyva.com / Gene.com



ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service

2017/08/25

NewswireToday (newswire) - 2017/08/25 Poway, CA United States - ProSci Incorporated, a San Diego-based privately held biotechnology firm, has announced the addition of flow cytometry to the list of antibody screening services offered for custom monoclonal antibody services - ProSci-Inc.com



FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors

2017/08/23

NewswireToday (newswire) - 2017/08/23 South San Francisco, CA United States - Application based on positive results of Phase III study in adults and adolescents with hemophilia A with inhibitors and interim Phase III results in children - Gene.com



BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles

2017/08/14

NewswireToday (newswire) - 2017/08/14 Franklin Lakes, NJ United States - BD (Becton, Dickinson and Company) has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the BD BACTEC™ Standard Aerobic and Standard Anaerobic blood culture bottles in plastic - BD.com



FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation

2017/08/07

NewswireToday (newswire) - 2017/08/07 South San Francisco, CA United States - Genentech announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental New Drug Application (sNDA) and granted Priority Review for Zelboraf® (vemurafenib) for Erdheim-Chester disease (ECD) with BRAF V600 mutation



Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers

2017/08/07

NewswireToday (newswire) - 2017/08/07 San Francisco, CA United States - Twist Bioscience announced that it signed a non-exclusive agreement with Synbio Technologies - TwistBioscience.com / Synbio-Tech.com



Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)

2017/07/21

NewswireToday (newswire) - 2017/07/21 Paris, Ile-de-France France - Ipsen receives positive CHMP opinion for approval of Xermelo® (telotristat ethyl), for the treatment of carcinoid syndrome diarrhea in patients inadequately controlled by somatostatin analogue therapy - IPSEN.com



BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System

2017/07/19

NewswireToday (newswire) - 2017/07/19 Franklin Lakes, NJ United States - BD FACSLyric™ Flow Cytometer System with BD Multitest™ Assays Offers Reliability and Consistency - BDBioSciences.com



Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

2017/07/10

NewswireToday (newswire) - 2017/07/10 South San Francisco, CA United States - Data from both studies have been submitted to FDA and EMA for approval consideration - Gene.com